Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Approval crawled date : 2020 - 12 - 17 save search
Waterstone Financial Declares First Quarter 2021 Dividend; Board Approves 66% Payment Increase
Published: 2020-12-17 (Crawled : 23:01) - globenewswire.com
WSBF | $12.335 6.8% 6.36% 130K
|
Finance
|
| O: 0.93%
H: 0.43%
C: 0.05%
approval
Gold Resource Corporation Approves Spin-Off of Fortitude Gold Corporation and Announces Record and Distribution Dates
Published: 2020-12-17 (Crawled : 23:01) - globenewswire.com
GORO 4 | $0.47 -5.98% 1.79% 650K
|
Non-Energy Minerals
|
| O: 1.77%
H: 0.44%
C: -4.35%
distribution approval
FDA Approves Labeling Update for Abbott's HeartMate 3 Heart Pump for use in Pediatric Patients
Published: 2020-12-17 (Crawled : 22:12) - prnewswire.com
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 0.06%
H: 0.7%
C: 0.11%
heart fda approval fda approval
FDA Approves Amgen's RIABNI™ (rituximab-arrx), A Biosimilar To Rituxan® (rituximab)
Published: 2020-12-17 (Crawled : 22:01) - biospace.com/
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.3%
H: 0.99%
C: 0.93%
fda approval fda approval biosimilar
CNS Pharmaceuticals Announces Call to Discuss FDA IND Approval and Phase 2 Trial for Berubicin
Published: 2020-12-17 (Crawled : 22:00) - biospace.com/
CNSP | News | $0.2002 -4.67% -4.9% 76K
|
Health Technology
|
| O: 28.72%
H: 6.2%
C: -10.91%
berubicin approval fda trial phase 2 fda ide
CNS Pharmaceuticals Announces FDA Approval of IND Application for its Brain Cancer Drug Candidate Berubicin
Published: 2020-12-17 (Crawled : 15:00) - biospace.com/
CNSP | News | $0.2002 -4.67% -4.9% 76K
|
Health Technology
|
| O: 28.72%
H: 6.2%
C: -10.91%
berubicin brain cancer fda approval fda approval cancer drug application train
ANI Pharmaceuticals Announces Approval and Launch of Aminocaproic Acid Tablets
Published: 2020-12-17 (Crawled : 15:00) - biospace.com/
ANIP S | $65.375 -1.16% -1.17% 83K
|
Health Technology
|
| O: 0.88%
H: 2.16%
C: 1.42%
approval
Amryt Receives Ministry of Health Reimbursement Approval for Lojuxta® (lomitapide) in Saudi Arabia
Published: 2020-12-17 (Crawled : 07:01) - globenewswire.com
AMYT | News | $14.7 0.0% 2.4M
|
Health Technology
|
| O: -1.28%
H: 2.37%
C: 2.37%
approval health
Zai Lab Partner MacroGenics Announces FDA Approval of MARGENZA™ for Patients with Pretreated Metastatic HER2-Positive Breast Cancer
Published: 2020-12-17 (Crawled : 02:00) - globenewswire.com
ZLAB | $15.66 3.57% 3.45% 430K
|
Health Technology
|
| O: 4.86%
H: 0.57%
C: 0.22%
MGNX | $15.7 -3.27% -3.38% 520K
|
Health Technology
|
| O: 11.44%
H: 2.33%
C: -10.52%
fda approval fda approval cancer breast cancer positive her2+ her2- her2
Cenovus and Husky announce Court of Queen’s Bench approval of proposed business combination
Published: 2020-12-17 (Crawled : 01:00) - globenewswire.com
CVE | $21.23 -0.19% 0.02% 5.9M
|
Energy Minerals
|
| O: 1.36%
H: 0.83%
C: 0.0%
approval
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.